Literature DB >> 22417256

Clinical practice. Uncomplicated urinary tract infection.

Thomas M Hooton1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417256     DOI: 10.1056/NEJMcp1104429

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  175 in total

1.  Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.

Authors:  A Gündoğdu; Y B Long; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-24       Impact factor: 3.267

2.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

3.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping.

Authors:  Begoña Heras; Makrina Totsika; Kate M Peters; Jason J Paxman; Christine L Gee; Russell J Jarrott; Matthew A Perugini; Andrew E Whitten; Mark A Schembri
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-13       Impact factor: 11.205

5.  A Rare Opportunist, Morganella morganii, Decreases Severity of Polymicrobial Catheter-Associated Urinary Tract Infection.

Authors:  Brian S Learman; Aimee L Brauer; Kathryn A Eaton; Chelsie E Armbruster
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

6.  Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully.

Authors:  Vrushali Patwardhan; Sarman Singh
Journal:  Int Urol Nephrol       Date:  2017-06-14       Impact factor: 2.370

7.  Digital Quantification of DNA Replication and Chromosome Segregation Enables Determination of Antimicrobial Susceptibility after only 15 Minutes of Antibiotic Exposure.

Authors:  Nathan G Schoepp; Eugenia M Khorosheva; Travis S Schlappi; Matthew S Curtis; Romney M Humphries; Janet A Hindler; Rustem F Ismagilov
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-30       Impact factor: 15.336

8.  Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Authors:  Yanping Luo; Yanning Ma; Qiang Zhao; Leili Wang; Ling Guo; Liyan Ye; Youjiang Zhang; Jiyong Yang
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.

Authors:  Elisabetta Costantini; Alessandro Zucchi; Eleonora Salvini; Annarita Cicalese; Vincenzo Li Marzi; Maria Teresa Filocamo; Vittorio Bini; Massimo Lazzeri
Journal:  Int Urogynecol J       Date:  2014-02-20       Impact factor: 2.894

10.  Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial.

Authors:  Thomas M Hooton; Mariacristina Vecchio; Alison Iroz; Ivan Tack; Quentin Dornic; Isabelle Seksek; Yair Lotan
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.